Therefore, OxS can exacerbate platelet aggregation in MetS by changing the intracellular peroxide and peroxynitrite levels, culminating in TxA2 and F2-isoprostanes overproduction, a mechanism at least partially regulated by Nox2. The gene discussed is CYBB; the disease is metabolic syndrome.